세계의 산소포화도 측정기 시장 : 제품별, 유형별, 기술별, 연령층별, 최종사용자별, 지역별 - 예측(-2032년)

The global pulse oximeters market is projected to reach USD 7.04 billion by 2032 from USD 3.60 billion in 2024, at a CAGR of 8.7% during the forecast period. Growth in this market is mainly driven by the increasing number of surgical procedures, the growing geriatric population, and the increasing incidence of chronic diseases.

By product, the equipment segment is expected to register the highest CAGR during the forecast period.

Based on the product, the pulse oximeters market is segmented into sensors and equipment. The equipment segment is expected to register the highest growth rate during the forecast period. The high growth rate of this segment is attributed to the increasing demand for fingertip pulse oximeters for home monitoring and the rising number of surgeries requiring patient monitoring devices.

By type, the bedside/tabletop pulse oximeter segment accounted for the largest share of the pulse oximeters market in 2024.

Based on type, the pulse oximeters market is segmented into portable pulse oximeters and bedside/tabletop pulse oximeters. The market for portable pulse oximeters is further segmented into fingertip, handheld, and wearable pulse oximeters. In 2024, the bedside/tabletop pulse oximeters segment accounted for the largest share of the pulse oximeters market. The large share of this market is attributed to increasing adoption of bedside pulse oximeters for patient monitoring in home-care settings and long-term care facilities.

By technology, the conventional devices segment accounted for the largest market share of the pulse oximeters market in 2024.

Based on technology, the pulse oximeters market is segmented into conventional and connected devices. In 2024, the conventional devices segment accounted for a larger market share of the pulse oximeters market. The large share of this segment is attributed to the adoption of wired pulse oximeters in conjunction with other patient monitoring devices in healthcare settings. Conventional pulse oximeters are still widely used because they are cost-effective, simple to operate, and offer proven clinical accuracy. They do not rely on the internet or Bluetooth connectivity, making them ideal for resource-limited settings. Hospitals trust their reliability for critical care and surgical monitoring. Connected devices often face adoption barriers due to data privacy concerns and infrastructure needs. Additionally, conventional models require less maintenance and training

By age group, the pediatric pulse oximeter segment is expected to register the highest CAGR during the forecast period.

Based on age group, the pulse oximeters market is segmented into adults (18 and over) and pediatrics (neonates under 1 month, infants between 1 month and 2 years of age, children between 2 and 12 years, and adolescents between 12 and 16 years). The pediatric segment is expected to register the highest growth during the forecast period. The high growth rate of this segment is attributed to the increasing cases of congenital heart diseases and other respiratory diseases, leading to hospital admissions and rising surgical procedures for children.

By end users, the homecare settings segment is expected to register the highest CAGR during the forecast period.

Based on end users, the pulse oximeters market has been segmented into hospitals, home care settings, and ambulatory care centers. The home care settings segment is expected to register the highest growth during the forecast period. The large share of this segment can be attributed to the widespread adoption of portable pulse oximeters for remote patient monitoring.

By region, North America accounted for the largest market share in 2024.

In 2024, North America accounted for the largest share of the pulse oximeters market. The surge in the geriatric population in the coming years and the subsequent rise in hospitalizations, the growing incidence of infectious diseases, and the rising technological advancements in pulse oximeters are the factors driving the growth of the pulse oximeters market in the region.

The breakdown of primary participants was as mentioned below:

• By Company Type - Tier 1-35%, Tier 2-45%, and Tier 3-20%
• By Designation - C-level-35%, Director-level-25%, Others-40%
• By Region - North America-45%, Europe-30%, the Asia Pacific-20%, Latin America- 3%, and the Middle East and Africa-2%

Key Players in Pulse Oximeters Market

The key players operating in the pulse oximeters market are Medtronic plc (Ireland), Masimo Corporation (US), Koninklijke Philips N.V. (Netherlands), Nonin Medical Inc. (US), Nihon Kohden Corporation (Japan), GE Healthcare (US), CONTEC MEDICAL SYSTEMS CO., LTD. (China), ICU Medical, Inc. (US), Dragerwerk AG & Co. KGaA (Germany), OSI Systems, Inc. (Spacelabs Healthcare) (US), Meditech Equipment Co., Ltd. (China), Medline Industries, LP (US), ChoiceMMed (China), and Dr Trust (US), among others.

Research Coverage:

The report analyzes the pulse oximeters market and estimates its size and future growth potential based on various segments such as product, type, technology, age group, end user, and region. It also includes a product portfolio matrix of various pulse oximetry products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report

The report will help established firms, new entrants, and smaller firms gauge the pulse of the market, which in turn would help them gain a more significant share of the market. Firms purchasing the report could use one or any combination of the strategies mentioned below to strengthen their position in the market.

This report provides insights into the following pointers:

• Analysis of key drivers (increasing prevalence of chronic disease, technological advancements in pulse oximeters, new product launches, high R&D investments), restraints (Accuracy in OTC pulse oximeters), opportunities (emerging markets and the growing adoption of pulse oximeters), challenges (usage of pulse oximeters)
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the pulse oximeters market
• Product Development/Innovation: Detailed insights into the upcoming trends, R&D activities, and product launches in the pulse oximeters market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the Pulse oximeters market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH APPROACH
  • 2.1.1 SECONDARY RESEARCH
    • 2.1.1.1 Key sources of secondary data
    • 2.1.1.2 Key data from secondary sources
  • 2.1.2 PRIMARY RESEARCH
    • 2.1.2.1 Key primary sources
    • 2.1.2.2 Key objectives of primary research
    • 2.1.2.3 Key data from primary sources
    • 2.1.2.4 Key insights from industry experts
    • 2.1.2.5 Breakdown of primaries
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 REVENUE SHARE ANALYSIS
  • 2.2.2 MARKET SHARE ANALYSIS (BOTTOM-UP APPROACH)
  • 2.2.3 TOP-DOWN APPROACH
  • 2.2.4 PRIMARY INTERVIEWS
• 2.3 DATA TRIANGULATION
• 2.4 MARKET SHARE ESTIMATION
• 2.5 STUDY ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
  • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.6.2 SCOPE-RELATED LIMITATIONS
• 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 PULSE OXIMETER MARKET OVERVIEW
• 4.2 ASIA PACIFIC: PULSE OXIMETER MARKET, BY END USER AND COUNTRY
• 4.3 PULSE OXIMETER MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Growing incidence of chronic respiratory diseases
    • 5.2.1.2 Increasing prevalence of congenital heart diseases in children
    • 5.2.1.3 Rising number of surgical procedures and hospitalizations
    • 5.2.1.4 Rise in geriatric population and associated chronic diseases
    • 5.2.1.5 Technological advancements in pulse oximeter devices
    • 5.2.1.6 Advancements in healthcare infrastructure and high private & public Investments
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Regulations and accuracy concerns for OTC pulse oximeters
    • 5.2.2.2 Poor healthcare infrastructure in low- and middle-income countries
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Expansion of medical device companies in emerging economies
    • 5.2.3.2 Rising demand for remote pulse oximeter market in home care settings
    • 5.2.3.3 Growing preference for non-invasive devices and point-of-care testing
    • 5.2.3.4 Increased adoption of telemedicine and remote patient monitoring
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Technological advancements by key market players
    • 5.2.4.2 Development of alternative smart devices
• 5.3 INDUSTRY TRENDS
  • 5.3.1 PREFERENCE FOR WIRELESS CONNECTIVITY AND ADOPTION OF SMARTPHONE-BASED HEALTHCARE APPLICATIONS
  • 5.3.2 ADOPTION OF NEXT-GENERATION PULSE OXIMETRY
• 5.4 TECHNOLOGY ANALYSIS
  • 5.4.1 KEY TECHNOLOGIES
    • 5.4.1.1 Advanced optical engines
    • 5.4.1.2 Integrated medical devices
  • 5.4.2 COMPLEMENTARY TECHNOLOGIES
    • 5.4.2.1 Bluetooth and wireless connectivity
    • 5.4.2.2 Remote pulse oximeter platforms
• 5.5 PORTER'S FIVE FORCES ANALYSIS
  • 5.5.1 THREAT OF NEW ENTRANTS
  • 5.5.2 THREAT OF SUBSTITUTES
  • 5.5.3 BARGAINING POWER OF SUPPLIERS
  • 5.5.4 BARGAINING POWER OF BUYERS
  • 5.5.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.6 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.6.2 KEY BUYING CRITERIA
• 5.7 REGULATORY ANALYSIS
  • 5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.7.2 REGULATORY FRAMEWORK
    • 5.7.2.1 North America
      • 5.7.2.1.1 US
      • 5.7.2.1.2 Canada
    • 5.7.2.2 Europe
    • 5.7.2.3 Asia Pacific
      • 5.7.2.3.1 Japan
      • 5.7.2.3.2 China
      • 5.7.2.3.3 India
• 5.8 PATENT ANALYSIS
  • 5.8.1 PATENT PUBLICATION TRENDS FOR PULSE OXIMETERS
  • 5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.8.3 LIST OF MAJOR PATENTS
• 5.9 TRADE ANALYSIS
  • 5.9.1 IMPORT DATA FOR HS CODE 901819
  • 5.9.2 EXPORT DATA FOR HS CODE 901819
• 5.10 PRICING ANALYSIS
  • 5.10.1 AVERAGE SELLING PRICE TREND OF PULSE OXIMETERS, BY KEY PLAYER, 2022-2024
  • 5.10.2 AVERAGE SELLING PRICE TREND OF FINGERTIP PULSE OXIMETERS, BY REGION, 2022-2024
• 5.11 KEY CONFERENCES & EVENTS, 2025-2026
• 5.12 UNMET NEEDS/END-USER EXPECTATIONS
• 5.13 VALUE CHAIN ANALYSIS
• 5.14 CASE STUDY ANALYSIS
  • 5.14.1 CASE STUDY 1: MASIMO TO PROVIDE COVID-19 HOME MONITORING WITH FINGERTIP OXIMETERS
  • 5.14.2 CASE STUDY 2: NONIN TO MANUFACTURE WEARABLE PULSE OXIMETERS FOR SLEEP APNEA DIAGNOSIS
  • 5.14.3 CASE STUDY 3: PHILIPS HEALTHCARE TO FOCUS ON PEDIATRIC MONITORING IN NEONATAL ICUS
• 5.15 ADJACENT MARKET ANALYSIS
• 5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.17 ECOSYSTEM ANALYSIS
• 5.18 INVESTMENT & FUNDING SCENARIO
• 5.19 IMPACT OF AI/GEN AI ON PULSE OXIMETER MARKET
• 5.20 IMPACT OF 2025 US TARIFF ON PULSE OXIMETER MARKET
  • 5.20.1 KEY TARIFF RATES
  • 5.20.2 PRICE IMPACT ANALYSIS
  • 5.20.3 IMPACT ON COUNTRY/REGION
    • 5.20.3.1 North America
      • 5.20.3.1.1 US
      • 5.20.3.1.2 Europe
      • 5.20.3.1.3 Germany
      • 5.20.3.1.4 UK and France
    • 5.20.3.2 Asia Pacific
      • 5.20.3.2.1 China
      • 5.20.3.2.2 Japan
      • 5.20.3.2.3 India
  • 5.20.4 IMPACT ON END-USE INDUSTRIES
    • 5.20.4.1 Hospitals
    • 5.20.4.2 Ambulatory surgery centers
    • 5.20.4.3 Primary centres
    • 5.20.4.4 Home care centers
    • 5.20.4.5 Urgent care centers

6 PULSE OXIMETER MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 SENSORS
  • 6.2.1 DISPOSABLE SENSORS
    • 6.2.1.1 Increasing adoption of disposable sensors in home care settings to drive market
  • 6.2.2 REUSABLE SENSORS
    • 6.2.2.1 Rising need for continuous patient monitoring to support market growth
• 6.3 EQUIPMENT
  • 6.3.1 GROWING ADOPTION OF OTC PULSE OXIMETERS IN HOME CARE AND AMBULATORY SETTINGS TO SUPPORT DEMAND

7 PULSE OXIMETER MARKET, BY TYPE

• 7.1 INTRODUCTION
• 7.2 PORTABLE PULSE OXIMETERS
  • 7.2.1 HANDHELD PULSE OXIMETERS
    • 7.2.1.1 Portability, versatility, and better usage for point-of-care devices to propel segment growth
  • 7.2.2 FINGERTIP PULSE OXIMETERS
    • 7.2.2.1 Rising popularity of over-the-counter devices in home care settings to aid segment growth
  • 7.2.3 WEARABLE PULSE OXIMETERS
    • 7.2.3.1 Rising demand for remote patient monitoring in home healthcare settings to spur adoption
• 7.3 BEDSIDE/TABLETOP PULSE OXIMETERS
  • 7.3.1 IMPROVED HEALTHCARE INFRASTRUCTURE AND HIGH INCIDENCE OF CARDIOVASCULAR DISEASES TO SUPPORT MARKET GROWTH

8 PULSE OXIMETER MARKET, BY TECHNOLOGY

• 8.1 INTRODUCTION
• 8.2 CONVENTIONAL PULSE OXIMETERS
  • 8.2.1 LACK OF CONTINUOUS PATIENT HEALTH MONITORING FACILITY TO LIMIT MARKET ADOPTION
• 8.3 CONNECTED PULSE OXIMETERS
  • 8.3.1 HIGH ADOPTION OF BLUETOOTH-ENABLED DEVICES TO SUPPORT MARKET GROWTH

9 PULSE OXIMETER MARKET, BY AGE GROUP

• 9.1 INTRODUCTION
• 9.2 ADULTS
  • 9.2.1 HIGH BURDEN OF CHRONIC RESPIRATORY DISEASES TO DRIVE MARKET
• 9.3 PEDIATRIC
  • 9.3.1 INFANTS
    • 9.3.1.1 Availability of sensors as per child weight to augment adoption of handheld oximeters
  • 9.3.2 NEONATAL
    • 9.3.2.1 Increasing number of preterm and low-weight births to fuel market growth

10 PULSE OXIMETER MARKET, BY END USER

• 10.1 INTRODUCTION
• 10.2 HOSPITALS
  • 10.2.1 HIGH FINANCIAL CAPABILITIES FOR PURCHASING EXPENSIVE EQUIPMENT AND AVAILABILITY OF TRAINED PROFESSIONALS TO DRIVE MARKET
• 10.3 HOME CARE SETTINGS
  • 10.3.1 OTC HOME USE
    • 10.3.1.1 Rising adoption of OTC pulse oximeters for chronic respiratory diseases to boost market growth
  • 10.3.2 PRESCRIPTION HOME USE
    • 10.3.2.1 Increased Adoption of prescription oximeters for asthma management to propel market
• 10.4 AMBULATORY CARE CENTERS
  • 10.4.1 COST-EFFECTIVENESS AND FAVORABLE REIMBURSEMENT SCENARIO TO AID MARKET GROWTH
• 10.5 URGENT CARE CENTERS
  • 10.5.1 URGENT CARE CENTERS TO PROVIDE FASTEST MOBILE RESPONSE FOR NON-EMERGENCY SITUATIONS
• 10.6 PRIMARY CENTERS
  • 10.6.1 PRIMARY CENTERS TO FOCUS ON PREVENTIVE CARE, MATERNAL & CHILD HEALTH, IMMUNIZATION, AND HEALTH EDUCATION
• 10.7 OTHER END USERS

11 PULSE OXIMETER MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 US
    • 11.2.1.1 US to dominate North American pulse oximeter market during study period
  • 11.2.2 CANADA
    • 11.2.2.1 Increasing prevalence of chronic respiratory ailments and lung cancer to drive demand
• 11.3 EUROPE
  • 11.3.1 GERMANY
    • 11.3.1.1 Favorable reimbursement initiatives for medical treatment to propel market growth
  • 11.3.2 FRANCE
    • 11.3.2.1 Decrease in mortality rate and high government healthcare expenditure to support adoption of pulse oximeters
  • 11.3.3 UK
    • 11.3.3.1 Rising incidence of COPD and cardiovascular diseases to drive market
  • 11.3.4 ITALY
    • 11.3.4.1 Improving quality and accessibility to medical care to fuel adoption of pulse oximeters
  • 11.3.5 SPAIN
    • 11.3.5.1 Favorable government initiatives and advanced healthcare infrastructure to augment market growth
  • 11.3.6 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 JAPAN
    • 11.4.1.1 Presence of universal health policy and high geriatric population to drive demand for pulse oximeters
  • 11.4.2 CHINA
    • 11.4.2.1 Increased hospital admission rates and high government healthcare investments to drive market
  • 11.4.3 INDIA
    • 11.4.3.1 Growing prevalence of respiratory diseases to drive demand for advanced pulse oximeters
  • 11.4.4 AUSTRALIA
    • 11.4.4.1 Escalating burden of chronic diseases to propel adoption of pulse oximeters
  • 11.4.5 SOUTH KOREA
    • 11.4.5.1 Rapidly aging society and improved healthcare system to augment market growth
  • 11.4.6 REST OF ASIA PACIFIC
• 11.5 LATIN AMERICA
  • 11.5.1 BRAZIL
    • 11.5.1.1 Limited access to healthcare reimbursements to restrain market growth
  • 11.5.2 MEXICO
    • 11.5.2.1 Favorable government policies for foreign medical device manufacturers to support market growth
  • 11.5.3 REST OF LATIN AMERICA
• 11.6 MIDDLE EAST & AFRICA
  • 11.6.1 GCC COUNTRIES
    • 11.6.1.1 Kingdom of Saudi Arabia (KSA)
      • 11.6.1.1.1 Rising geriatric population and increasing burden of non-communicable illnesses to aid market growth
    • 11.6.1.2 UAE
      • 11.6.1.2.1 High burden of respiratory diseases to spur market growth
    • 11.6.1.3 Rest of GCC Countries
  • 11.6.2 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

• 12.1 INTRODUCTION
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PULSE OXIMETER MARKET
• 12.3 REVENUE ANALYSIS, 2020-2024
• 12.4 MARKET SHARE ANALYSIS, 2024
• 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 12.5.1 STARS
  • 12.5.2 EMERGING LEADERS
  • 12.5.3 PERVASIVE PLAYERS
  • 12.5.4 PARTICIPANTS
  • 12.5.5 COMPANY FOOTPRINT, KEY PLAYERS, 2024
    • 12.5.5.1 Company footprint
    • 12.5.5.2 Region footprint
    • 12.5.5.3 Product & type footprint
    • 12.5.5.4 Age group footprint
    • 12.5.5.5 Technology footprint
    • 12.5.5.6 End-user footprint
• 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 12.6.1 PROGRESSIVE COMPANIES
  • 12.6.2 DYNAMIC COMPANIES
  • 12.6.3 RESPONSIVE COMPANIES
  • 12.6.4 STARTING BLOCKS
  • 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 12.6.5.1 Detailed list of key startups/SMEs
    • 12.6.5.2 Competitive benchmarking of startups/SMEs
• 12.7 BRAND/PRODUCT COMPARISON
• 12.8 COMPANY VALUATION & FINANCIAL METRICS
  • 12.8.1 FINANCIAL METRICS
  • 12.8.2 COMPANY VALUATION
• 12.9 COMPETITIVE SCENARIO

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 MEDTRONIC
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Product approvals
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Key strengths
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses & competitive threats
  • 13.1.2 MASIMO
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Product launches & approvals
      • 13.1.2.3.2 Deals
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Key strengths
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses & competitive threats
  • 13.1.3 NIHON KOHDEN CORPORATION
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Product launches
      • 13.1.3.3.2 Deals
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Key strengths
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses & competitive threats
  • 13.1.4 KONINKLIJKE PHILIPS N.V.
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Deals
    • 13.1.4.4 MnM view
      • 13.1.4.4.1 Key strengths
      • 13.1.4.4.2 Strategic choices
      • 13.1.4.4.3 Weaknesses & competitive threats
  • 13.1.5 ICU MEDICAL, INC.
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products offered
    • 13.1.5.3 Recent developments
      • 13.1.5.3.1 Product upgrades
      • 13.1.5.3.2 Deals
    • 13.1.5.4 MnM view
      • 13.1.5.4.1 Key strengths
      • 13.1.5.4.2 Strategic choices
      • 13.1.5.4.3 Weaknesses & competitive threats
  • 13.1.6 NONIN
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Product approvals
      • 13.1.6.3.2 Deals
  • 13.1.7 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products offered
  • 13.1.8 GE HEALTHCARE
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products offered
    • 13.1.8.3 Recent developments
      • 13.1.8.3.1 Product approvals
      • 13.1.8.3.2 Deals
  • 13.1.9 CONTEC MEDICAL SYSTEMS CO., LTD.
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products offered
    • 13.1.9.3 Recent developments
      • 13.1.9.3.1 Product launches
  • 13.1.10 DRAGERWERK AG & CO. KGAA
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products offered
    • 13.1.10.3 Recent developments
      • 13.1.10.3.1 Product launches & approvals
      • 13.1.10.3.2 Deals
  • 13.1.11 OSI SYSTEMS, INC.
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products offered
    • 13.1.11.3 Recent developments
      • 13.1.11.3.1 Deals
  • 13.1.12 QINGDAO MEDITECH EQUIPMENT CO., LTD. (MEDITECH GROUP)
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products offered
  • 13.1.13 CHOICEMMED
    • 13.1.13.1 Business overview
    • 13.1.13.2 Products offered
    • 13.1.13.3 Recent developments
      • 13.1.13.3.1 Deals
  • 13.1.14 A&D COMPANY, LIMITED
    • 13.1.14.1 Business overview
    • 13.1.14.2 Products offered
  • 13.1.15 BPL MEDICAL TECHNOLOGIES
    • 13.1.15.1 Business overview
    • 13.1.15.2 Products offered
    • 13.1.15.3 Recent developments
      • 13.1.15.3.1 Product launches
• 13.2 OTHER PLAYERS
  • 13.2.1 VIATOM TECHNOLOGY, CO., LTD.
  • 13.2.2 BERRY MEDICAL HEALTHCARE SDN BHD
  • 13.2.3 MICROLIFE CORPORATION
  • 13.2.4 TENKO MEDICAL SYSTEM CORP.
  • 13.2.5 BEURER GMBH
  • 13.2.6 SHENZHEN AEON TECHNOLOGY CO., LTD.
  • 13.2.7 BITMOS GMBH
  • 13.2.8 TECNO-GAZ S.P.A.
  • 13.2.9 OMRAN HEALTHCARE, INC.
  • 13.2.10 HUM GMBH

14 APPENDIX

• 14.1 INSIGHTS OF INDUSTRY EXPERTS
• 14.2 DISCUSSION GUIDE
• 14.3 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.4 CUSTOMIZATION OPTIONS
• 14.5 RELATED REPORTS
• 14.6 AUTHOR DETAILS